News

Back to Careers

CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO 2025 in Boston to discuss how emerging therapeutic categories are reshaping dealmaking strategies and how the success of GLP-1/GIP therapies in promoting weight loss is driving a new era in chronic disease treatments